Journal of Hepatology
Volume 39, Issue 2 , Pages 187-192, August 2003

Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety☆☆☆

  • Justiniano Santos

      Affiliations

    • Department of Gastroenterology, Hospital Universitari Germans Trı́as i Pujol, Carretera del Canyet, s/n, 08916 Badalona, Spain
    • ,
  • Ramon Planas

      Affiliations

    • Department of Gastroenterology, Hospital Universitari Germans Trı́as i Pujol, Carretera del Canyet, s/n, 08916 Badalona, Spain
    • Corresponding Author InformationCorresponding author. Tel./fax: +34-93-497-8951
    • ,
  • Albert Pardo

      Affiliations

    • Department of Gastroenterology, Hospital Universitario de Canarias, Tenerife, Spain
    • ,
  • Rosa Durández

      Affiliations

    • Department of Gastroenterology, Hospital Universitari Germans Trı́as i Pujol, Carretera del Canyet, s/n, 08916 Badalona, Spain
    • ,
  • Eduard Cabré

      Affiliations

    • Department of Gastroenterology, Hospital Universitari Germans Trı́as i Pujol, Carretera del Canyet, s/n, 08916 Badalona, Spain
    • ,
  • Rosa Maria Morillas

      Affiliations

    • Department of Gastroenterology, Hospital Universitari Germans Trı́as i Pujol, Carretera del Canyet, s/n, 08916 Badalona, Spain
    • ,
  • Maria Luisa Granada

      Affiliations

    • Department of Biochemistry, Hospital Universitari Germans Trı́as i Pujol, 08916 Badalona, Spain
    • ,
  • José Angel Jiménez

      Affiliations

    • Department of Radiology, Hospital Universitari Germans Trı́as i Pujol, 08916 Badalona, Spain
    • ,
  • Enrique Quintero

      Affiliations

    • Department of Gastroenterology, Hospital Universitario de Canarias, Tenerife, Spain
    • ,
  • Miquel Angel Gassull

      Affiliations

    • Department of Gastroenterology, Hospital Universitari Germans Trı́as i Pujol, Carretera del Canyet, s/n, 08916 Badalona, Spain

Received 18 June 2002; received in revised form 18 March 2003; accepted 1 April 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Preliminary results of this study were presented at the 50th Annual Meeting of the American Association for the Study of Liver diseases held in Dallas (November, 1999) and the 35th Annual Meeting of the European Association for the Study of the Liver held in Rotterdam (April–May, 2000).

☆☆ The authors who have taken part in this study have not a relationship with the manufacturers of the drugs involved either in the past or present and did not receive funding from the manufacturers to carry out their research.

PII: S0168-8278(03)00188-0

doi:10.1016/S0168-8278(03)00188-0

Journal of Hepatology
Volume 39, Issue 2 , Pages 187-192, August 2003

Article Tools

* Image Usage & Resolution